• March 28, 2024

PMI issues scientific update

 PMI issues scientific update

The latest issue of Philip Morris International’s Scientific Update for Smoke-Free Products focuses on PMI’s scientific assessment program as it applies to its Electronically Heated Tobacco Product (EHTP).

In a press note yesterday announcing the publication of the update, Professor Manuel Peitsch, PMI’s chief scientific officer was quoted as saying that the company had developed a truly world class R&D program to assess scientifically the potential of its smoke-free products to reduce risk.

“With each progressive step of our assessment of EHTP, we have seen a significant reduction in exposure to a number of harmful chemicals and risk potential compared with cigarettes,” he said.

“Because transparency is a vital part of our program, we are making our evidence available for others to review.”

The note said the focus was on PMI’s scientific assessment program as it applied to its EHTP, referred to in the literature as the tobacco heating system (THS).

‘PMI established its multi-step assessment program applying internationally accepted scientific and quality standards along the same principles as the US Food and Drug Administration (FDA) draft guidance (2012),’ the note said.

‘The feature article outlines each step of the assessment program and summarizes key results of supporting data. Included is an overview of the more than 30 EHTP-related studies. PMI submitted this evidence to the FDA in the form of a modified risk tobacco product (MRTP) application.

‘Beyond the MRTP-related content, the Scientific Update provides an overview of the assessment to date on its smoke-free product portfolio. The issue also covers key presentations at scientific conferences. It is an important complement to PMI’s ongoing efforts to share its latest science, which include a dedicated website…

‘PMI’s extensive research and assessment program is inspired by the well-recognized practices of the pharmaceutical industry and in line with guidance of the US FDA for MRTPs. The Company today employs over 400 world-class scientists, engineers and experts who conduct rigorous research, including laboratory and clinical studies, as well as ground-breaking systems toxicology. The assessment program also includes studies on actual product use and correct understanding of product communications, as well as post-market research.’

The update is at: https://www.pmiscience.com/system/files/publications/pmi_scientific_update_november_2017.pdf.